Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma.
Ruan
Jia
J
Division of Hematology/Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. jruan@med.cornell.edu
Leonard
John P
JP
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D042501:Angiogenic Proteins / Q000037:antagonists & inhibitors; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D042501:Angiogenic Proteins